🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Malignant Tumor

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration NCT07718165Phase 11 site📍 Shanghai Abbisko Therapeutics Co, Ltd · Tests: ABSK211 A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites📍 Boston📍 St Louis📍 Hackensack BeOne Medicines · Tests: BG-C0979, Tislelizumab Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors NCT05596344n/a1 site📍 Zhengzhou Henan Cancer Hospital · Tests: Hospital Anxiety and Depression Scale A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites📍 Phoenix📍 Los Angeles📍 Orlando Iovance Biotherapeutics, Inc. · Tests: Lifileucel Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment NCT05661461Phase 12 sites📍 San Antonio📍 West Valley City Aadi Bioscience, Inc. · Tests: nab-sirolimus ABlative Radiotherapy (for) Unfavorable Prostate Tumors NCT04831983n/a1 site📍 Monza University of Milano Bicocca "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site📍 Zhuhai Ming-Yuan Chen · Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participants… A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001） NCT05357651Phase 11 site📍 Shanghai L & L Bio Co., Ltd., Ningbo, China · Tests: LB1410 A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors NCT05938309n/a1 site📍 Fuzhou Fujian Medical University Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites📍 Birmingham📍 New Haven📍 St Louis BeOne Medicines · Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations NCT06947811Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Almonertinib, Palbociclib MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site📍 Hangzhou Zhejiang University · Tests: MT027 CAR-T cells Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Pancreatic elastase-1 in blood serum ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) NCT06415487Phase 19 sites📍 San Diego📍 Denver📍 Nashville Acepodia Biotech, Inc. · Tests: Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221Phase 1, Phase 298 sites📍 Gilbert📍 Duarte📍 Irvine Revolution Medicines, Inc. · Tests: RMC-6291, RMC-6236, Pembrolizumab, Cisplatin, Carboplatin Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection NCT05620017Phase 12 sites📍 Chongqing📍 Hangzhou Bio-Thera Solutions · Tests: BAT8008 for Injection TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: TILs（Tumor Infiltrating Lymphocytes） Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia NCT05281809Phase 21 site📍 Pittsburgh John Lister · Tests: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous) Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry NCT04996732n/a1 site📍 Shanghai Fudan University · Tests: hospitalization A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) NCT07137598Phase 265 sites📍 Avondale📍 Peoria📍 La Jolla Hoffmann-La Roche · Tests: Afimkibart, Placebo A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions NCT07532538n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… Contribution of 3D Modeling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors NCT06418243n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010) NCT07785609Phase 24 sites📍 San Antonio📍 Hong Kong📍 Bellinzona Merck Sharp & Dohme LLC · Tests: MK-2010, Sacituzumab tirumotecan, Histamine H1 Receptor Antagonist, Histamine H2 Receptor Antagonist, Acetaminophen (or… A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites📍 Los Angeles📍 Denver📍 Nashville RasCal Therapeutics, Inc. · Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy